Mohammad Mahdi Sepahi

ORCID: 0009-0001-5264-2545
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Concrete and Cement Materials Research
  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Graphene and Nanomaterials Applications
  • Healthcare professionals’ stress and burnout
  • Education and Critical Thinking Development
  • Engineering and Material Science Research
  • Ethics in medical practice
  • Innovations in Medical Education
  • Animal Virus Infections Studies
  • Ethics in Business and Education
  • Fire effects on concrete materials
  • COVID-19 and healthcare impacts
  • Carbon and Quantum Dots Applications
  • Graphene research and applications
  • Viral Infections and Immunology Research

University of Isfahan
2024

Sapienza University of Rome
2024

University of Tehran
2024

Imam Khomeini International University
2021

The ever-increasing construction demand for the human and high energy consumption of production raw material has a significant impact on environmental pollution. One challenges facing civil engineers is to understand behavior concrete during exposure elevated temperatures, their service life performance after exposure. In this study, possibility partial replacement cement with metakaolin improvement properties investigated. dosage 10, 15, 20% weight. After determining optimum percentage at...

10.1080/21650373.2021.1877206 article EN Journal of Sustainable Cement-Based Materials 2021-03-08

Introduction: In the nursing profession, a suitable level of moral reasoning increases quality care for patients and boosts job satisfaction among nurses. Professional identity self-confidence, feeling belonging to establishing interpersonal communication in people. This study was conducted determine relationship between Kohlberg's ethical professional students. Method: this correlation study, 231 undergraduate students faculties affiliated with Birjand University Medical Sciences were...

10.18502/jmed.v19i3.17342 article EN cc-by-nc Journal of Medical Education and Development 2024-12-28

The repeated COVID-19 outbreaks, despite global vaccination, highlights the need for booster doses. Here, we present outcomes, up until day 90 post of a randomized, double-blind, placebo-controlled phase 1 clinical trial mRNA-based vaccine candidate; COReNAPCIN ® , as dose in adults aged 18-50 who had previously received three doses inactivated vaccines. In study, 30 participants randomly (2:2:1) 25 μg, or 50 μg placebo. results indicated that was well tolerated vaccinated individuals both...

10.1101/2023.11.01.23297898 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2023-11-02
Coming Soon ...